Top Japanese Stocks To Own For 2014

George Soros is heartened by current efforts to revive growth in the world’s major economies, the hapless eurozone being the one exception.

“All of the looming problems for the global economy are political in character,” he writes.

The U.S. is showing its muscle as the developed world’s strongest economy on several counts:

“More surprising, the polarization of American politics shows signs of reversing,” Soros writes, the fever apparently having broken after the recent government shutdown.

In Japan, Prime Minister Shinzo Abe is launched on a “risky experiment” of massive quantitative easing in order to reinvigorate a long-stagnant economy. “Faster growth could drive up interest rates, making debt-servicing costs unsustainable,” Soros writes, but Abe and the Japanese man in the street consider the risk worth taking.

But “the major uncertainty facing the world today is lies in the future direction of China,” he writes. “The growth model responsible for its rapid rise has run out of steam.” This constrained the household sector, now only 35% of GDP, in order to drive export and investment growth. But the forced savings can no longer finance the current growth model, leading to a huge rise in the use of various forms of debt financing.

Top 10 Valued Stocks To Own Right Now: Zep Inc.(ZEP)

Zep Inc. produces and markets cleaning and maintenance chemicals, and related products and services for commercial, industrial, institutional and consumer applications. Its products include anti-bacterial and industrial hand care products, cleaners, degreasers, deodorizers, disinfectants, floor finishes, sanitizers, pest- and weed-control products, air-care products and delivery systems, and various automotive maintenance chemicals. The company markets its products and services under various brands, such as Zep, Selig, ArmorAll, Niagara, Enforcer, Zep Commercial, RedMax Pro, Rubbermaid Commercial, Original Bike Spirits, Country Vet, Zep Professional, Microbemax, Misty, TimeMist, i-Chem, TimeWick, and Next Dimension brands, as well as private label and original equipment manufacturer private brands. It serves customers in industrial maintenance, janitorial/sanitation, and automotive markets; transportation, food processing, industrial manufacturing, and food service industr ies; and contractors, small business owners, and homeowners in the United States, Canada, and Europe. The company was founded in 1937 and is headquartered in Atlanta, Georgia.

Advisors' Opinion:

• [By Seth Jayson]

  When judging a company's prospects, how quickly it turns cash outflows into cash inflows can be just as important as how much profit it's booking in the accounting fantasy world we call "earnings." This is one of the first metrics I check when I'm hunting for the market's best stocks. Today, we'll see how it applies to Zep (NYSE: ZEP  ) .

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Zep (NYSE: ZEP  ) , whose recent revenue and earnings are plotted below.

• [By Seth Jayson]

  Basic guidelines
  In this series, I examine inventory using a simple rule of thumb: Inventory increases ought to roughly parallel revenue increases. If inventory bloats more quickly than sales grow, this might be a sign that expected sales haven't materialized. Is the current inventory situation at Zep (NYSE: ZEP  ) out of line? To figure that out, start by comparing the company's inventory growth to sales growth. How is Zep doing by this quick checkup? At first glance, not so great. Trailing-12-month revenue increased 3.5%, and inventory increased 11.8%. Comparing the latest quarter to the prior-year quarter, the story looks decent. Revenue grew 7.7%, and inventory grew 11.8%. Over the sequential quarterly period, the trend looks OK but not great. Revenue grew 3.4%, and inventory grew 4.7%.

Top Japanese Stocks To Own For 2014: Sangamo BioSciences Inc.(SGMO)

Sangamo Biosciences, Inc. engages in the research, development, and commercialization of zinc finger DNA-binding proteins (ZFPs) for gene regulation and gene modification in the United States. Its ZFPs could be engineered to make ZFP transcription factors (ZFP TFs), proteins that could be used to turn genes on or off; and ZFP nucleases (ZFNs), proteins that enable to modify DNA sequences in various ways. The company?s principal ZFP therapeutic include SB-509, a plasmid formulation of a ZFP TF activator of the vascular endothelial growth factor-A (VEGF-A) gene that is in a Phase 2b clinical trial for the treatment of severe diabetic neuropathy; and in a Phase 2 clinical trial in for the treatment of amyotrophic lateral sclerosis, as well as in preclinical animal studies for spinal cord injury, traumatic brain injury, and stroke. It is also developing SB-728-T, a ZFN-modified T-cell product, which is in Phase 1/2 clinical trial and two Phase 1 trials for the treatment of HI V/AIDS. In addition, the company develops SB-313xTZ, a ZFN-based therapeutic that is in Phase 1 clinical trial for the treatment of glioblastoma multiforme, a type of brain cancer. Further, it has preclinical development programs of ZFP therapeutics in the areas of Parkinson?s disease, hemophilia B, and neuropathic pain; and neuroregenerative programs in spinal cord injury, traumatic brain injury, and stroke. Additionally, the company has research stage programs in the areas of monogenic diseases and genetic conditions that result from a defect in a single gene, including hemophilia and other hemoglobinopathies, and immunodeficiencies. It has collaboration agreements with Sigma-Aldrich Corporation; Dow AgroSciences LLC; Pfizer Inc.; Genentech, Inc.; Open Monoclonal Technology, Inc.; and F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. The company was founded in 1995 and is headquartered in Richmond, California.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Sangamo Biosciences (NASDAQ: SGMO) shot up 29.01 percent to $17.61 after the company and Biogen Idec (NASDAQ: BIIB) announced the global collaboration to develop treatments for hemoglobinopathies.

• [By John McCamant, Editor, Medical Technology Stock Letter]

  The company-Sangamo (SGMO)-expects that TALE architectures to be broadly adopted and become the industry standard.

  When combined with Sangamo's proprietary engineered ZFP technology, or DNA cutting domains, the TALE technology can be harnessed to efficiently and precisely edit gene sequences.

• [By Jake L'Ecuyer]

  Among the sector stocks, Albany Molecular Research (NASDAQ: AMRI) was down more than 13 percent, while Sangamo Biosciences (NASDAQ: SGMO) tumbled around 6 percent.

Top Japanese Stocks To Own For 2014: Datalink Corporation(DTLK)

Datalink Corporation data center solutions and services to mid and large-size companies in the United States. It engages in assessing, designing, deploying, and supporting infrastructures, such as servers, storage, and networks; and reselling hardware and software from original equipment manufacturers. The company?s portfolio of solutions and services comprise consolidation and virtualization services; data storage and protection services, including local and remote backup, disaster recovery, archive, and compliance services; advanced network infrastructure services that includes assessment, design, and deployment of network infrastructures; and business continuity and disaster recovery solutions. It also offers a suite of practice-specific consulting, analysis, design, implementation, management, and support services. Datalink Corporation was founded in 1958 and is headquartered in Chanhassen, Minnesota.

Advisors' Opinion:

• [By Lauren Pollock]

  Datalink Corp.(DTLK), a provider of data-center infrastructure and service, boosted its fourth-quarter earnings outlook amid expectations that its revenue will be stronger than previously anticipated. Shares surged 31% to $14.20 premarket.

Top Japanese Stocks To Own For 2014: Hannover House Inc (HHSE)

Hannover House, Inc., formerly Target Development Group, Inc., is the parent company of Hannover House. Hannover House is a full service media company, specializing in the production and distribution of feature films onto the digital versatile disc (DVD) format for the North American retail marketplace. As of December 31, 2010, the Company had over 70 DVD titles in active distribution. In June 2012, the Company acquired nine feature films for video release in North America.

Retailers carrying Hannover House products include independently owned and operated retail video stores and book stores, including Barnes & Noble, Best Buy, Blockbuster Video, Borders Group, Fred Meyer Group, Hastings, SAM�� Club, Transworld Group and Wal-Mart. It also includes Internet retailers.

Advisors' Opinion:

• [By Peter Graham]

  Small cap tech or media stocks Thinspace Technology Inc (OTCMKTS: THNS), Beamz Interactive Inc (OTCBB: BZIC) and Hannover House Inc (OTCMKTS: HHSE) have been getting some extra attention lately, but it appears that only one of these stocks has been the subject of a paid promotion. Nevertheless, all three stocks have been busy with press releases trying to get the attention of investors or traders. So are these three small cap tech or media stocks worth your attention? Here is a closer look along with a reality check:

Top Japanese Stocks To Own For 2014: Saes Getters SpA (SG&A)

SAES Getters SpA is an Italy-based company primarily engaged in the production of getters and metal dispensers. The Company structures its business into three main units: Industrial Applications, which includes getters and metal dispensers used in light sources and electron vacuum devices, getters for microelectronic and micromechanical systems, pumps for vacuum systems, getters for solar collectors, products for thermal insulation, and gas purifier systems; Shape Memory Alloys, which includes shape memory alloy semi-finished products, components and devices for medical and industrial applications, and Information Displays, which includes getters and metal dispensers for liquid crystal displays, and barium getters for cathode ray tubes. Additionally, through the Business Development Unit, the Company produces dryers and getters for organic light-emitting diode (OLED), sealants for solar panels and energy storage getter devices. Advisors' Opinion:

• [By Jason Rivera]

  To help facilitate this destruction of value has been that Koss has bought back a lot of its shares as the company has been overvalued. The below quote is from its most recent annual report.
  In April of 1995, the Board of Directors approved a stock repurchase program authorizing the Company to purchase from time to time up to $2,000,000 of its common stock for its own account. Subsequently, the Board of Directors periodically has approved increases in the stock repurchase program. As of June 30, 2012, the most recently approved increase was for additional purchases of $2,000,000, which occurred in October of 2006, for an aggregate maximum of $45,500,000, of which $43,360,247 had been expended through June 30, 2012 . No purchases were made during the year ended June 30, 2012. The Company intends to effect all stock purchases either on the open market or through privately negotiated transactions and intends to finance all stock purchases through its own cash flow or by borrowing for such purchases.As you can see from this page, most of KOSS' margins have dropped substantially since 2007. Especially of note is its operating margin, ROE and ROIC. Book value per share, cash flow per share, revenue and working capital have all dropped substantially as well. Normally when I have evaluated companies' cost of goods sold rising is what has caused the above metrics to drop, but that has stayed relatively stable over the years at KOSS. The culprit in this case is selling, general and administrative (SG&A) related expenses expressed below as a percentage of its sales. The following numbers were taken from Morningstar:

• [By GURUFOCUS]

  For investors, Qualcomm understand the benefits of cloud services. It seems there are numerous questions unresolved. Over the last decade, pharmaceutical companies have been aggregating years of research and development data into medical databases, initiating overhauls of its R&D and selling, general and administrative (SG&A) segments for Pharma. A company willing to build their capabilities, and open to a new view of value will likely achieve better outcomes. Delivering support, personalization, scalability, speed and flexibility are attractive areas for growth.

Top Japanese Stocks To Own For 2014: Nevsun Resources Ltd (NSU)

Nevsun Resources Ltd. is a Canadian mineral resource company. The Company, through its subsidiaries is engaged in the acquisition, exploration, development, and production of mineral properties. Its primary operating asset is the Bisha Mine located on the Bisha Property with gold, silver and base metal (copper and zinc) mineral resources and mineral reserves. In addition, the Company owns the Mogoraib exploration license containing 97.4 square kilometers of area located 16 kilometers southwest of the Bisha Mine, and a mining licence for the Harena deposit, located approximately 9 kilometers south of the Bisha Mine. The Bisha Mine is owned by BMSC, the voting securities of which are held 60% by the Company and 40% by ENAMCO. During the year ended December 31, 2012, diamond drilling programs were undertaken across Bisha Main, Bisha Hangingwall (HW) Copper, Harena and the Northwest (NW) Zone, for a total of approximately 115 holes and 19,432 meters. Advisors' Opinion:

• [By Rich Smith]

  In a terse, 101-word announcement, Vancouver-based and Eritrea-operating gold-mining company Nevsun Resources (NYSEMKT: NSU  ) announced the departure of its CFO on Wednesday.